| Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV AM Lambeir, C Durinx, S Scharpé, I De Meester Critical reviews in clinical laboratory sciences 40 (3), 209-294, 2003 | 1237 | 2003 |
| The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety M Maes, C Song, A Lin, R De Jongh, A Van Gastel, G Kenis, E Bosmans, ... Cytokine 10 (4), 313-318, 1998 | 1010 | 1998 |
| CD26, let it cut or cut it down I De Meester, S Korom, J Van Damme, S Scharpé Immunology today 20 (8), 367-375, 1999 | 679 | 1999 |
| Proline motifs in peptides and their biological processing G Vanhoof, F Goossens, I De Meester, D Hendriks, S Scharpé The FASEB Journal 9 (9), 736-744, 1995 | 590 | 1995 |
| Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X‐Pro dipeptides C Durinx, AM Lambeir, E Bosmans, JB Falmagne, R Berghmans, ... European Journal of Biochemistry 267 (17), 5608-5613, 2000 | 359 | 2000 |
| Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family AM Lambeir, P Proost, C Durinx, G Bal, K Senten, K Augustyns, ... Journal of Biological Chemistry 276 (32), 29839-29845, 2001 | 348 | 2001 |
| Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV: conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection P Proost, I De Meester, D Schols, S Struyf, AM Lambeir, A Wuyts, ... Journal of Biological Chemistry 273 (13), 7222-7227, 1998 | 341 | 1998 |
| Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α P Proost, S Struyf, D Schols, C Durinx, A Wuyts, JP Lenaerts, E De Clercq, ... FEBS letters 432 (1-2), 73-76, 1998 | 261 | 1998 |
| Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients1, 2 S Korom, I De Meester, THW Stadlbauer, A Chandraker, M Schaub, ... Transplantation 63 (10), 1495-1500, 1997 | 240 | 1997 |
| Dipeptidyl-Peptidase IV Converts Intact B-Type Natriuretic Peptide into Its des-SerPro Form I Brandt, AM LAMbEiR, JM Ketelslegers, M Vanderheyden, ... Clinical chemistry 52 (1), 82-87, 2006 | 227 | 2006 |
| Extended structure–activity relationship and pharmacokinetic investigation of (4-quinolinoyl) glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP) K Jansen, L Heirbaut, R Verkerk, JD Cheng, J Joossens, P Cos, L Maes, ... Journal of medicinal chemistry 57 (7), 3053-3074, 2014 | 214 | 2014 |
| Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression M Maes, HY Meltzer, S Scharpè, E Bosmans, E Suy, I De Meester, ... Psychiatry research 49 (2), 151-165, 1993 | 209 | 1993 |
| Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction P Proost, S Struyf, D Schols, G Opdenakker, S Sozzani, P Allavena, ... Journal of Biological Chemistry 274 (7), 3988-3993, 1999 | 205 | 1999 |
| The dipeptidyl peptidase family, prolyl oligopeptidase and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis Y Waumans, L Baerts, K Kehoe, AM Lambeir, I De Meester Frontiers in immunology 6, 146787, 2015 | 199 | 2015 |
| CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine … S Struyf, P Proost, D Schols, E De Clercq, G Opdenakker, JP Lenaerts, ... The Journal of immunology 162 (8), 4903-4909, 1999 | 197 | 1999 |
| Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist P Proost, P Menten, S Struyf, E Schutyser, I De Meester, J Van Damme Blood, The Journal of the American Society of Hematology 96 (5), 1674-1680, 2000 | 195 | 2000 |
| Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV E Van Coillie, P Proost, I Van Aelst, S Struyf, M Polfliet, I De Meester, ... Biochemistry 37 (36), 12672-12680, 1998 | 185 | 1998 |
| Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor S Struyf, I De Meester, S Scharpé, JP Lenaerts, P Menten, JM Wang, ... European journal of immunology 28 (4), 1262-1271, 1998 | 185 | 1998 |
| Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold K Jansen, L Heirbaut, JD Cheng, J Joossens, O Ryabtsova, P Cos, ... ACS medicinal chemistry letters 4 (5), 491-496, 2013 | 183 | 2013 |
| Regulation of intestinal permeability: the role of proteases H Van Spaendonk, H Ceuleers, L Witters, E Patteet, J Joossens, ... World journal of gastroenterology 23 (12), 2106, 2017 | 171 | 2017 |
